SCHEMBL7786157

SCHEMBL7786157

CC(C)(C)[Si](C)(C)OCCOc1ccc(Cl)cc1C=C1C(=O)Nc2cc(Cl)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 5/20 0.49
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48
TUBB8 Q3ZCM7 1/20 0.48
TUBA3E Q6PEY2 1/20 0.48
TUBA1A Q71U36 1/20 0.48
TUBA1C Q9BQE3 1/20 0.48
TUBB6 Q9BUF5 1/20 0.48
TUBB2B Q9BVA1 1/20 0.48
TUBB1 Q9H4B7 1/20 0.48
FLT3 P36888 2/20 0.44
PSEN1 P49768 3/20 0.43
PSEN2 P49810 3/20 0.43
APH1B Q8WW43 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711243 1.00 MDM2 (0.49) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3713915 1.00 MDM2 (0.49) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13929258 0.80 MDM2 (0.54) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13929375 0.79 MDM2 (0.53) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13929366 0.79 MDM2 (0.51) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4217742 0.78 MDM2 (0.52) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4217744 0.78 MDM2 (0.52) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6864464 0.78 TUBB4A (0.42) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2300891 0.78 TUBB4A (0.42) MDM2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7828821 0.78 MDM2 (0.52) MDM2TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217051-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-07-10 US disclosed
US-8217051-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-07-10 US disclosed
US-20100210674-A1 Spiroindolinone Derivatives HOFFMANN-LA ROCHE INC. 2010-08-19 US disclosed
US-20100210674-A1 Spiroindolinone Derivatives HOFFMANN-LA ROCHE INC. 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210674-A1 Spiroindolinone Derivatives RCC2, PKD1, SIK2 MDM2 1241/4885TUBB4A 412/4885TUBB 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.